Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:14 PM
Ignite Modification Date:
2025-12-24 @ 12:14 PM
NCT ID:
NCT04601961
Eligibility Criteria:
Inclusion Criteria:
All patients aged 18-80 years old with primary hepatocellular carcinoma presenting for elective open hepatectomy surgery in Queen Mary Hospital, Hong Kong, will be invited to join this randomised, controlled trial.
Exclusion Criteria:
Pre-operative factors
* Contraindication to general anaesthesia
* Autoimmune / Chronic inflammatory diseases e.g. Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis(RA) etc.
* Chemotherapy in the past year
* Steroid therapy
* Surgery for tumour removal in the past year
* patients post liver transplantation Intra-operative factors
* Regional Anaesthesia
Administration of:
* Nitrous oxide
* Inhalational agents (with the exception of sevoflurane)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04601961
Study Brief:
Protocol Section:
NCT04601961